You might want to check out $TSOI, which is currently trading at an incredibly low market cap despite having multiple FDA clinical phase 3 trials underway. They've even announced dividends in one of their nine privately held subsidiaries, with plans to do the same for others. With promising pipeline success in phase 3 trials, $TSOI could see significant growth potential, possibly reaching multiple dollars in value.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.